Select Biosciences South East Asia Pte. Ltd. and The Diagnostics Development Hub, DxD, part of Exploit Technologies Pte. Ltd. are pleased to present the inaugural Diagnostics Summit – Circulating Biomarkers for Liquid Biopsy Development and Companion Diagnostics, taking place on the 13-14 October 2016 at The Biopolis, Singapore’s custom built biomedical research and development hub, home to a large number of the
world’s leading Life Science organisations and A*STAR research institutes.
This conference will help to address the unmet clinical needs within this sector and provide a detailed overview of the current research, the latest innovations, the regulatory requirements, commercialisation of diagnostic innovations and market entry into Asia. Helping researchers and entrepreneurs transform their IP’s into clinically validated diagnostics devices.
There will be two conference tracks covering the following areas:
Track 1
- Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins
- Exosomes and Microvesicles
Track 2
- Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development
- Technology & Company Showcase, Commercialisation & the Regulatory Landscape
We are honoured to introduce the following Distinguished Experts who will be presenting at the meeting
* Guest of Honour Lim Chuan Poh, Chairman, A*STAR
Plenary Speakers
* Fred Kramer, Professor, New Jersey Medical School Rutgers University
* Jean-Luc Butel, Senior Advisor, McKinsey & Company, President, K8 Global
* Rudi Pauwels, Founder Director/Chief Executive Officer, Biocartis
* Chwee Teck Lim, Provost’s Chair Professor, National University of Singapore
Keynote Speakers
* Mike Makrigiorgos, Professor of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School
* A. Mark Richards, Director, Cardiovascular Research Institute (CVRI), NUHS
* David Wong, Director, University of California Los Angeles
* Antonio Chiesi, CEO, Exosomics Siena S.p.A.
* Patrick Tan, Deputy Executive Director, Biomedical Research Council
* Mahesh Choolani, Research Director , National University Health System (NUHS)
* David Ruff, Visiting Senior Research Fellow/ Principal Scientist , Oxford University/Fluidigm Corporation
Media Contact
Paul Raggett, CEO [email protected]
Select Biosciences South East Asia Pte. Ltd.
16 Raffles Quay, #33-03 Hong Leong Building, Singapore 048581
